Literature DB >> 18814919

Mid-pregnancy circulating cytokine levels, histologic chorioamnionitis and spontaneous preterm birth.

Julia Warner Gargano1, Claudia Holzman, Patricia Senagore, Poul Thorsen, Kristin Skogstrand, David M Hougaard, Mohammad H Rahbar, Hwan Chung.   

Abstract

Some spontaneous preterm deliveries (PTD) are caused by occult infections of the fetal membranes (histologic chorioamnionitis [HCA]). High levels of infection-related markers, including some cytokines, sampled from maternal circulation in mid-pregnancy have been linked to PTD, but whether these specifically identify HCA has not been established. We have tested associations between 13 Th1, Th2 and Th17 cytokines and PTD with and without HCA in a prospective cohort study. The study sample included 926 Pregnancy Outcomes and Community Health Study subcohort women; women with medically indicated PTD or incomplete data excluded. A panel of cytokines was assessed using a multiplex assay in maternal plasma collected at 15-27 weeks of gestation. Severe HCA was scored by a placental pathologist blinded to clinical variables. Multivariable polytomous logistic regression was used to estimate adjusted odds ratios (OR) per 1 standard deviation (S.D.) increase in cytokine levels using a 5 level outcome variable: PTD <35 weeks with HCA, PTD <35 weeks without HCA, PTD 35-36 weeks with HCA, PTD 35-36 weeks without HCA, and term (referent). Interleukin (IL)-1beta, IL-2, IL-12, interferon-gamma, IL-4, IL-6 and transforming growth factor-beta were all significantly associated with PTD <35 weeks with HCA, with ORs of 1.6-2.3 per S.D. increase. None of these were associated with PTD <35 weeks without HCA or PTD 35-36 weeks with HCA. Although the tissues of origin of circulating cytokines are unclear, the observed elevations across many cytokines among women who later delivered <35 weeks with HCA may represent a robust immune response to infection within gestational tissues. These results suggest that women with HCA could be identified using relatively non-invasive means.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18814919      PMCID: PMC2683663          DOI: 10.1016/j.jri.2008.08.006

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  40 in total

1.  Pregnancy outcomes and community health: the POUCH study of preterm delivery.

Authors:  C Holzman; B Bullen; R Fisher; N Paneth; L Reuss
Journal:  Paediatr Perinat Epidemiol       Date:  2001-07       Impact factor: 3.980

Review 2.  Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines.

Authors:  Abdelaziz Kharfi; Yves Giguère; Vincent Sapin; Jacques Massé; Bernard Dastugue; Jean-Claude Forest
Journal:  Clin Biochem       Date:  2003-07       Impact factor: 3.281

Review 3.  Th17 cells: effector T cells with inflammatory properties.

Authors:  Thomas Korn; Mohamed Oukka; Vijay Kuchroo; Estelle Bettelli
Journal:  Semin Immunol       Date:  2007-11-26       Impact factor: 11.130

4.  Early second-trimester inflammatory markers and short cervical length and the risk of recurrent preterm birth.

Authors:  Ida Vogel; Alice R Goepfert; Poul Thorsen; Kristin Skogstrand; David M Hougaard; Allison H Curry; Suzanne Cliver; William W Andrews
Journal:  J Reprod Immunol       Date:  2007-04-17       Impact factor: 4.054

5.  Histologic chorioamnionitis and preterm delivery.

Authors:  Claudia Holzman; Ximin Lin; Patricia Senagore; Hwan Chung
Journal:  Am J Epidemiol       Date:  2007-07-11       Impact factor: 4.897

6.  The preterm prediction study: granulocyte colony-stimulating factor and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Authors:  R L Goldenberg; W W Andrews; B M Mercer; A H Moawad; P J Meis; J D Iams; A Das; S N Caritis; J M Roberts; M Miodovnik; K Menard; G Thurnau; M P Dombrowski; D McNellis
Journal:  Am J Obstet Gynecol       Date:  2000-03       Impact factor: 8.661

Review 7.  An overview of mortality and sequelae of preterm birth from infancy to adulthood.

Authors:  Saroj Saigal; Lex W Doyle
Journal:  Lancet       Date:  2008-01-19       Impact factor: 79.321

8.  Maternal second-trimester serum ferritin concentrations and subsequent risk of preterm delivery.

Authors:  Rong Xiao; Tanya K Sorensen; Ihunnaya O Frederick; Amira El-Bastawissi; Irena B King; Wendy M Leisenring; Michelle A Williams
Journal:  Paediatr Perinat Epidemiol       Date:  2002-10       Impact factor: 3.980

9.  Maternal circulating interferon-gamma and interleukin-6 as biomarkers of Th1/Th2 immune status throughout pregnancy.

Authors:  Aziz Aris; Fréderic Lambert; Paul Bessette; Jean-Marie Moutquin
Journal:  J Obstet Gynaecol Res       Date:  2008-02       Impact factor: 1.730

10.  Histologic chorioamnionitis and umbilical serum levels of pro-inflammatory cytokines and cytokine inhibitors.

Authors:  Henrik Døllner; Lars Vatten; Jostein Halgunset; Shahnaz Rahimipoor; Rigmor Austgulen
Journal:  BJOG       Date:  2002-05       Impact factor: 6.531

View more
  31 in total

1.  The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes.

Authors:  Brian M Mercer; Dennis T Crouse; Robert L Goldenberg; Menachem Miodovnik; Delicia C Mapp; Paul J Meis; Mitchell P Dombrowski
Journal:  Am J Obstet Gynecol       Date:  2011-09-08       Impact factor: 8.661

2.  Clinical chorioamnionitis at term II: the intra-amniotic inflammatory response.

Authors:  Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Adi L Tarca; Gaurav Bhatti; Zhonghui Xu; Juan P Kusanovic; Zhong Dong; Nikolina Docheva; Alicia Martinez-Varea; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Perinat Med       Date:  2016-01       Impact factor: 1.901

3.  Snoring during pregnancy and delivery outcomes: a cohort study.

Authors:  Louise M O'Brien; Alexandra S Bullough; Jocelynn T Owusu; Kimberley A Tremblay; Cynthia A Brincat; Mark C Chames; John D Kalbfleisch; Ronald D Chervin
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

4.  Umbilical cord serum cytokine levels and risks of small-for-gestational-age and preterm birth.

Authors:  Gila I Neta; Ondine S von Ehrenstein; Lynn R Goldman; Kirsten Lum; Rajeshwari Sundaram; William Andrews; Jun Zhang
Journal:  Am J Epidemiol       Date:  2010-03-26       Impact factor: 4.897

5.  Associations of snoring frequency and intensity in pregnancy with time-to-delivery.

Authors:  Galit Levi Dunietz; Kerby Shedden; Enrique F Schisterman; Lynda D Lisabeth; Marjorie C Treadwell; Louise M O'Brien
Journal:  Paediatr Perinat Epidemiol       Date:  2018-09-28       Impact factor: 3.980

6.  HIV serostatus, viral load, and midtrimester cervical length in a Zambian prenatal cohort.

Authors:  Joan T Price; Bellington Vwalika; Jennifer Winston; Andrew Kumwenda; Mwansa K Lubeya; Katelyn J Rittenhouse; Elizabeth Stringer; Margaret P Kasaro; Jeffrey S A Stringer
Journal:  Int J Gynaecol Obstet       Date:  2019-04-29       Impact factor: 3.561

7.  Obstructive sleep apnea and the risk of preterm delivery.

Authors:  Kunyalak Na-Rungsri; Somrat Lertmaharit; Vitool Lohsoonthorn; Surachart Totienchai; Nattapong Jaimchariyatam
Journal:  Sleep Breath       Date:  2016-04-08       Impact factor: 2.816

8.  Sex-specific associations between prenatal negative life events and birth outcomes.

Authors:  Maria José Rosa; Farida Nentin; Michelle Bosquet Enlow; Michele R Hacker; Nastasia Pollas; Brent Coull; Rosalind J Wright
Journal:  Stress       Date:  2019-05-06       Impact factor: 3.493

9.  Obstructive sleep apnea as a risk factor for preeclampsia-eclampsia.

Authors:  Nattapong Jaimchariyatam; Kunyalak Na-Rungsri; Somkanya Tungsanga; Somrat Lertmaharit; Vitool Lohsoonthorn; Surachart Totienchai
Journal:  Sleep Breath       Date:  2018-11-27       Impact factor: 2.816

10.  Mononuclear leukocyte infiltrate in extraplacental membranes and preterm delivery.

Authors:  Claudia Holzman; Patricia K Senagore; Jianling Wang
Journal:  Am J Epidemiol       Date:  2013-02-20       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.